Integrated Diagnostics Holdings plc (IDGXF)

Market Cap	291.83M +39.4%
Revenue (ttm)	152.84M +36.1%
Net Income	26.63M +58.0%
EPS	0.05 +58.0%
Shares Out	n/a
PE Ratio	10.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.5764
Previous Close	n/a
Day's Range	0.5764 - 0.5764
52-Week Range	0.4476 - 0.6983
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2026

About IDGXF

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroe...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 7,137
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDGXF

Financial Performance

In 2025, IDGXF's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error